SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs breakout to a new 52-week high and bullish call-option activity are drawing attention ahead of the expected Q3 report, with traders watching BRIUMVIs sales momentum and guidance. Buyout speculation is adding to the excitement, but remains unconfirmed; some investors see the move as earnings positioning while others question whether expectations are already priced in.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Roots Hyundai Secure+ white-label insurance offering is drawing attention, with traders viewing the dealership channel as a potential source of policy growth while others question how quickly it will convert into business. The debate is set against concern about recent declines in policies in force and sluggish revenue growth, despite continued profitability.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

OXYs breakout to a six-month high and call-heavy options activity have drawn attention, alongside optimism that debt reduction and stronger free cash flow are improving the oil producers outlook. Traders are split between expecting further momentum and cautioning that the shares could stall after lagging crude at times.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1983 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Chenieres strong Q3 results, raised full-year guidance, dividend increase, and completion of its Corpus Christi expansion are driving attention as shares reach a new high. Many traders are bullish on the operating momentum, while some are taking profits or pointing to put-heavy options activity and the risk of a pause after the run-up.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron is drawing attention after a third-quarter earnings beat, with growth in Dupixent and Eylea HD helping offset pressure on legacy Eylea. Traders largely welcomed the results and sharp share move, while some question whether newer products can sustain growth amid biosimilar competition.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotifys latest quarterly report has driven attention: despite revenue and earnings coming in below expectations, subscriber growth, stronger gross margins, and a better-than-expected next-quarter profit outlook have been credited for the stocks sharp rise. Traders are debating the disconnect between the headline miss and the upbeat guidance, with some questioning whether higher expenses and the recent run-up make the rally sustainable.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA filing for sonelokimab in hidradenitis suppurativa and the pending FDA acceptance and review-timeline decision are the main focus, with traders debating whether regulatory progress can revive the stock. Bulls point to the clinical data and commercial potential, while bears emphasize approval risk and the costs of launching alone; buyout talk remains speculative.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Positive Phase 3 data for Amgens cancer and Sjgrens disease programs are reinforcing bullish momentum as the shares approach highs. Traders are also focused on upcoming quarterly results, with some viewing put activity as earnings protection rather than a bearish bet.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is drawing attention as traders position for further Nasdaq weakness, citing tech and AI-spending concerns alongside market volatility. Some expect a deeper selloff, while others warn that reports of a possible U.S.-Iran deal and Strait of Hormuz reopening could fuel a rebound and hurt short positions.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,811.032761 with 281,866,747.320393 in circulation. The last known price of OFFICIAL TRUMP is 1.57555883 USD and is down -1.93 over the last 24 hours. It is currently trading on 744 active market(s) with $126,884,732.61 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

The Trump-branded meme coin is drawing attention amid discussion of its steep decline and retail holders losses, with many traders calling it a cash grab. A smaller bullish contingent points to the recent bounce and speculates about an election-linked rebound or short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FHFAs move to place VantageScore alongside FICO on the mortgage pricing grid, combined with its lower pricing and Rocket Mortgages planned adoption, has raised concerns that FICO could lose mortgage-score market share and pricing powerdriving a sharp selloff. Traders remain divided: some view the plunge as overdone and point to approval of FICOs Direct License Program as a positive, while others see lasting damage to the companys competitive moat.

Fairway Home Mortgage, Movement Mortgage, Rate Join FICO Preferred Program

FICO (NYSE: FICO), global analytics software leader, today announced that Fairway Home Mortgage, Movement Mortgage and Rate have enrolled in the FICO Preferred Program and will continue to pull FICO Scores across their mortgage lending operations. Together, the three lenders represent a broad...

Grid Dynamics (GDYN) Tops Q3 Earnings and Revenue Estimates

Grid Dynamics (GDYN) delivered earnings and revenue surprises of +50.00% and +1.64%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Serve Robotics Inc. (SERV) to Report a Decline in Earnings: What to Look Out for

Serve Robotics Inc. (SERV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Fair Isaac (FICO) Reports Next Week: Wall Street Expects Earnings Growth

Fair Isaac (FICO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Vertiv Holdings Co. (VRT) Q3 Earnings and Revenues Surpass Estimates

Vertiv (VRT) delivered earnings and revenue surprises of +21.43% and +14.61%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Arvest Bank Upgrades to FICO Auto Score 10 to Enhance Auto Lending Precision

FICO (NYSE: FICO), global analytics software leader, today announced that Arvest Bank has successfully upgraded to FICO Auto Score 10, giving the regional lender a more precise view of borrower risk and strengthening its auto lending underwriting capabilities. The strategic move reflects Arvest...

FICO Holds Mortgage Score Pricing at $10 for Lenders Enrolled in Preferred Program

FICO (NYSE: FICO), global analytics software leader, today announced that it will hold its wholesale mortgage price for the FICO Score through its tri-merge resellers at $10 for lenders and brokers enrolled in its Preferred Program. The $10 price is for a bundle of both the Classic FICO Score, the...

Fair Isaac Corporation Announces Date for Reporting of Fourth Quarter Fiscal 2026 Financial Results

Global analytics software leader FICO (NYSE: FICO), will announce its fourth quarter fiscal 2026 results on November 4, 2026, after the market closes and will host a conference call on November 4th at 5:00 p.m. Eastern time (4:00 p.m. Central/ 2:00 p.m. Pacific). This call will be webcast and can...

August Breaks UK Credit Card Record as Balances Soar

According to data analysis from global analytics software leader FICO (NYSE: FICO), average active UK credit card balances exceeded 2,000 in August for the first time since records began, following three consecutive months of increases. Contributing to higher balances, payment rates dropped after a...

Independent Industry Experts Named to Judge 2027 FICO Decision Awards

Global analytics software leader FICO has announced its panel of independent judges for the 2027 FICO Decision Awards, which honor businesses achieving outstanding results using analytics and decision management technology to grow their business, manage risk and reduce costs.Our customers are...

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Stocktwits Wall Street Wrap: Analysts Turn Bullish On Sweetgreen, Target And Airbnb – Liquidia And FICO Face Downgrades

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Wells Fargo upgraded Sweetgreen and raised its price target, citing easing Cyclospora concerns and improving traffic.&nbsp;</li><li>HSBC upgraded Target, while KeyBanc raised Airbnb on durable growth and hotel expansion potential.&nbsp;</li><li>Wells Fargo and BTIG downgraded Liquidia after a court found Yutrepia infringed United Therapeutics patents.&nbsp;</li></ul><p>Six stocks are drawing fresh attention after Wall Street analysts changed their views on everything from restaurant traffic and retail demand to travel growth, patent risks and credit-score competition. Sweetgreen Inc. (SG), Target Corp. (<a class="mention" data-mention="$TGT" data-symbol-id="TGT" href="https://stocktwits.com/symbol/TGT" target="_blank">TGT</a>) and Airbnb Inc. (ABNB) received upgrades, while Liquidia Corp. (LQDA), Sea Ltd. (SE) and Fair Isaac Corp. (FICO) faced downgrades or sharply lower price targets.&nbsp;</p><h2 class="st-heading-2">Cyclospora Concerns Ease As Sweetgreen Traffic Shows Signs Of Recovery&nbsp;</h2><p>Wells Fargo upgraded Sweetgreen to ‘Overweight’ from ‘Equal Weight’ and lifted its price target to $11 from $6 after discussions with management. The firm said concerns tied to the Cyclospora outbreak appear to be easing, while Sweetgreen’s operational changes are starting to show results.</p><p>Wells Fargo said Sweetgreen was not responsible for the Cyclospora incident, but the episode hurt demand across the salad category. The company now sees customer traffic improving, while the analyst expects management could rely more on pricing to help absorb higher costs.</p><p>Sweetgreen shares have fallen 80% from their November 2024 peak, but improving traffic, new wraps and the end of the Cyclospora outbreak could support a recovery.&nbsp;<a href="https://stocktwits.com/symbol/SG">Sweetgreen stock</a> has gained over 5% so far this week and is on track for a fourth week of gains.&nbsp;</p><figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261002_054252505_d7d79db7eb.png" alt="koyfin_20261002_054252505.png" width="2400" height="1240"></figure><h2 class="st-heading-2">HSBC Turns Bullish On Target, Airbnb Could Grow Beyond Core Rentals&nbsp;</h2><p>HSBC upgraded Target to ‘Buy’ from ‘Hold’ and raised its price target to $190 from $125. Analyst Joe Thomas pointed to the retailer’s Q2 performance as evidence that customer visits are improving and that its turnaround efforts are gaining traction. HSBC also sees room for earnings to surpass current expectations.</p><p>KeyBanc&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/abnb-stock-eyes-snapping-4-week-losing-streak-key-banc-upgrades-airbnb-on-hotel-growth-valuation/cZDSvbKRB0m">upgraded</a> Airbnb to ‘Overweight’ from ‘Sector Weight’ and set a $191 price target. Analyst Sergio Segura said Airbnb’s main business continues to grow steadily, while hotel bookings could become a new source of growth.&nbsp;</p><p>While&nbsp;<a href="https://stocktwits.com/symbol/TGT">Target stock</a> was down 0.4% this week,&nbsp;<a href="https://stocktwits.com/symbol/ABNB">Airbnb stock</a> has gained nearly 2%.&nbsp;</p><h2 class="st-heading-2">Yutrepia Patent Dispute Creates Fresh Uncertainty For Liquidia&nbsp;</h2><p>Wells Fargo downgraded Liquidia to ‘Equal Weight’ from ‘Overweight’ and slashed its target to $30 from $108. The firm cited greater uncertainty for the company after a court&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lqda-stock-eyes-worst-day-ever-after-judge-upholds-two-uthr-patent-claims/cZMFSOCRBL0">ruling</a> and expressed limited confidence that Liquidia will prevail on appeal.</p><p>A Delaware judge ruled that Liquidia’s Yutrepia infringes two United Therapeutics (UTHR) patent claims. Both offer inhaled treprostinil treatments for pulmonary arterial hypertension (PAH) and PH-ILD . United sells Tyvaso products, while Liquidia’s Yutrepia, approved in 2025, is a dry-powder competitor. The disputed patent covers using inhaled treprostinil to improve exercise ability in PH-ILD patients.&nbsp;</p><p>BTIG separately lowered Liquidia to ‘Neutral’ from ‘Buy’, citing that the judgment could potentially halt Yutrepia across indications until the pulmonary hypertension indication is removed from its label.&nbsp;<a href="https://stocktwits.com/symbol/LQDA">Liquidia stock&nbsp;</a>is on track for its worst week ever with a 59% crash.</p><h2 class="st-heading-2">DBS Bank Cuts Sea Rating While BofA Flags Risks For FICO&nbsp;</h2><p>DBS Bank downgraded Sea to ‘Hold’ from ‘Buy’ and cut its price target to $105 from $148. The firm said Shopee is gaining strength but higher spending is hurting margins. It also faces competition from PDD’s cross-border business and Shopee’s push into quick commerce.&nbsp;</p><p>BofA moved Fair Isaac to ‘Neutral’ from ‘Buy’ and cut its price target to $700 from $1,400 after the Federal Housing Finance Agency placed VantageScore 4.0 and Classic FICO on the same loan-pricing adjustment framework. BofA said the change could encourage lenders to consider VantageScore more widely, creating additional risks for FICO’s pricing, volume and market share.</p><p><a href="https://stocktwits.com/symbol/SE">Sea stock</a> is heading for a fifth straight week of losses, with a 4.3% decline, while&nbsp;<a href="https://stocktwits.com/symbol/FICO">Fair Isaac stock</a> is down 23% and is on track for its worst month since March.&nbsp;</p><p>So far this year, SG, <a class="mention" data-mention="$TGT" data-symbol-id="TGT" href="https://stocktwits.com/symbol/TGT" target="_blank">TGT</a> and ABNB stocks gained between 18% and 60%, while LQDA, SE and FICO stocks crashed between 18% and 60%&nbsp;</p><p>Also see:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nke-stock-heads-for-a-weekly-loss-morningstar-says-nike-s-fresh-cost-cuts-signal-a-longer-road-to-recovery/cZDj37eRBKb">NKE Stock Heads For A Weekly Loss: Morningstar Says Nike's Fresh Cost Cuts Signal A Longer Road To Recovery</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Shoppers walk past the entrance to a Target store in Washington, DC.

Six stocks are drawing fresh attention after Wall Street analysts changed their views on everything from restaurant traffic and retail demand to travel growth, patent risks and credit-score competition. Sweetgreen Inc. (SG), Target Corp. (TGT) and Airbnb 

The changes reflect new views on restaurant demand, retail traffic, travel growth, drug risks and competition in financial data.


Airbnb Inc

Fair, Isaac Corp.

Liquidia Corp

Sea Ltd - ADR

Sweetgreen Inc - Ordinary Shares - Class A

Target Corp

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$711.23
Prev Close	$709.18
Open	$705.79
Dividend Yield	0.00%
50-Day Moving Average	$871.81
Beta	0.91
Avg. Volume	744,654.13
PE Ratio	20.55

52-Week High	$1,858.91
52-Week Low	$586.05
Market Capitalization	$15.36B
EPS (Annual)	$26.54
Price to Book	-4.13
Revenue Per Employee	$522,400.68

Feed

News

Sentiment

Earnings

Fundamentals

Info

FICO Fundamentals